|
HS Code |
399206 |
As an accredited 4-Bromo-1-[(4-Methylphenyl)Sulfonyl]-1H-Pyrrolo[2,3-B]Pyridine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 4-Bromo-1-[(4-Methylphenyl)Sulfonyl]-1H-Pyrrolo[2,3-B]Pyridine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Many folks in chemistry, especially those diving into medicinal or organic research, look for molecules that go beyond the basics. 4-Bromo-1-[(4-Methylphenyl)Sulfonyl]-1H-Pyrrolo[2,3-B]Pyridine draws attention for good reason: it brings together brominated heterocycle chemistry with a sulfonyl group closely tethered to a tolyl ring, all in one well-defined structure. A mix of these features opens up opportunities not easily found in everyday lab stock. For people working on kinase inhibitors, receptor binding studies, or the slow and steady grind of new molecule screening, this compound offers a combination of reactivity and selectivity that sets it apart from run-of-the-mill building blocks.
This molecule combines several chemical motifs. Pyrrolo[2,3-b]pyridine forms a rigid, bicyclic scaffold well known across bioactive compounds. Attaching a 4-bromo group gives chemists room for selective transformation, especially through palladium-catalyzed cross-coupling reactions. Across the ring system, the 4-methylphenyl sulfonyl group enters the picture, changing both the electronic and steric environment in ways that synthetic chemists appreciate. Over the years, I’ve worked with similar compounds to dial in selectivity, especially for creating libraries or targeting active sites that respond to a certain spatial arrangement. Having tried to swap out different sulfonyl and halogen groups on aromatic systems, I’ve learned that even small shifts can make or break a synthetic sequence—something this molecule handles with more flexibility than most.
It’s not enough to simply point to the structure and say it’s unique. You have to see what it can do, and what sets it apart on your bench. With 4-Bromo-1-[(4-Methylphenyl)Sulfonyl]-1H-Pyrrolo[2,3-B]Pyridine, you’re looking at a fine balance between stability under varied reaction conditions and the ability to function as a reactive intermediate. The combination of aromatic bromide (ready for carbon–carbon bond formation) and the strong electron-withdrawing sulfonyl group often makes this compound less prone to degradation than simple bromo-pyridines. From lab experience, this means less time cleaning up messy reactions and more time working on transformations that really matter in the final step.
People in medicinal chemistry know well: you need new cores and unique scaffolds, mostly because micro-variations in a molecule’s setup mean everything for binding affinity and downstream toxicity. Over the past decade, one major hurdle in drug discovery comes from “me-too” compounds saturating patent landscapes and research pipelines. Pulling in a molecule like this—where a complex fused pyridine isn’t just decorated with a halogen, but fully functionalized with a sulfonylated tolyl ring—lets research teams sketch out truly novel chemical spaces.
Beyond drug development, this compound supports advanced materials synthesis. Rigid bicyclic frameworks don’t just appear in medicinal settings; they’re used in polymers and light-emitting devices that need distinct stacking or conjugation properties. In academic settings, the classroom focus often leans into textbook transformations, but active researchers know the frustration of molecules degrading or failing basic scale-up. In my earlier days, even prepping quantities for metabolic or absorption studies brought headaches from inconsistent intermediates. This backbone grants resilience across a range of solvents and temperatures, which turns out to be essential for anyone scaling up or moving into less forgiving conditions.
There are other bromo-substituted pyrrolo[2,3-b]pyridines in the market, and a handful of sulfonyl derivatives float around in specialized catalogs. Most can’t merge the needed reactivity in one package. Using separate brominated and sulfonylated compounds sounds easy on paper, but, as those who’ve tried know all too well, merging them late in a synthesis invites purification nightmares and yield drops. Streamlining with a pre-assembled, structurally diverse molecule not only saves time; it dodges the double batch problem—a constant thorn in the side of process chemists looking to reduce cycle times and keep costs in check.
From a research standpoint, what you really get with this product is greater hit diversity during high-throughput screening. Many targets, from kinases to ion channels, respond distinctly to slight changes in core rigidity or electronic bias. In previous years, handling more typical heterocycles led to clusters of samey results that got lost in the shuffle. After adding this type of sulfonylated, brominated scaffold to the lineup, unique activity profiles started cropping up—especially in cell-based assays where subtle conformational preferences mean life or death for a project.
For anyone working on cross-coupling, the bromine atom unlocks standard Suzuki or Buchwald-Hartwig strategies. You can build complexity on top of an already elaborate starting point, slashing weeks off exploratory synthesis. I’ve talked to colleagues running parallel medicinal chemistry efforts; many admit that starting with more tailored cores is the only way to meet deadlines and avoid getting scooped on patent filings.
Bioactivity screens gain from the “beyond rule-of-five” design this structure allows. Sulfonyl groups aren’t just inert decorations; they can tip the balance between cell permeability and solubility. More than once, a molecule hit the “dumpster” file for being too greasy or for giving up in water. With this hybrid, the tolyl sulfonyl helps split the difference between hydrophobic and hydrophilic effects. Experience shows that structures like this can be dialed in for prodrug strategies, especially when a masked sulfonyl group is required to slip past stringent biological membranes.
Materials science groups look to heterocyclic-fused compounds for their optical profiles and stacking behaviors. I’ve seen how minor changes in ring systems affect thin film formation and emission wavelengths. The sulfonyl group, in this context, helps avoid uncontrolled aggregation while promoting useful interactions between chromophores. Prototype OLED materials or high-stability functional coatings have gotten a performance bump by integrating this stable, relatively planar molecule into larger arrays.
Researchers often ask about solubility and stability. 4-Bromo-1-[(4-Methylphenyl)Sulfonyl]-1H-Pyrrolo[2,3-B]Pyridine comes through as a crystalline powder, storing well under standard dry, cool conditions. Its aromatic system keeps hydrolysis at bay, while the sulfonyl and bromo substituents strengthen the backbone against unwanted oxidation. During more than one long-term storage experiment in our group, I found this compound held its color and consistency, even when lesser heterocycles turned yellow or showed degradation on TLC after a week. It’s remarkably tolerant of both polar aprotic and moderate protic solvents, broadening the kind of chemistry you can run or the delivery vehicles you can try.
In practical terms, synthetic accessibility means you get predictable results at scale. Several years ago, scaling up similar molecules led to crystallization problems—fat, waxy residues that clogged filtration and drove up costs. By contrast, this compound’s lattice structure grants neat, filterable solids that don’t over-absorb solvents. This alone can make a difference during purification, whether for medicinal, agrochemical, or advanced polymer work.
It’s not just about purity or synthetic yield. Market alternatives sometimes boast similar backbone motifs, but switching out a methyl for an ethyl or a para-phenyl for a meta- can disrupt key properties. My own attempts at synthesizing near cousins to this compound, with minor tweaks, led to drastic changes in melting points, processability, and reactivity. The sulfonyl-linked tolyl in the para position delivers a sweet spot that fosters both solubility and chemical activity.
Most pyrrolo[2,3-b]pyridine derivatives carrying only a bromo group lack the extra tuning needed for binding or downstream tailoring. By pairing that with the sulfonyl-toluene group, this product sets itself apart from libraries filled with too-similar heterocycles. Those subtle regional tweaks, missed by inexperienced chemists, pay off in real-world tests. Medicinal teams looking to sign off a hit compound know this type of modular, richly functionalized starting point can make or break the next batch of patent applications.
Not all specialty chemicals arrive in the condition sellers promise. Freshly purchased batches have at times turned out inconsistent, especially in moisture content or leftover solvents from rushed purification. In research projects where I’ve relied on off-the-shelf intermediates, I’ve seen entire synthetic runs fail because of hidden impurities. With 4-Bromo-1-[(4-Methylphenyl)Sulfonyl]-1H-Pyrrolo[2,3-B]Pyridine, vendors catering to this niche often aim for research-grade purity—vital for both analytical and downstream chemistry. Consistent melting points and clean spectral data support reliable tracking and regulatory filings, a factor not easily overlooked as regulations around chemical traceability tighten year over year.
Supply chain stability changes the game, especially with increased scrutiny on precursor sources and compliance. Over the last few years, tighter import rules and greater demands for product traceability made it essential for chemists to choose compounds already characterized through high-resolution NMR and mass spec techniques. Products with incomplete traceability and characterization no longer fly, whether for grant-funded projects or commercial R&D. Unannounced changes in synthetic route or batch purity risk derailing key experiments—an expensive setback not everyone can afford.
Complexity in chemical libraries and the growing dependence on intricate scaffolds spark discussion about the sustainability and accessibility of specialty intermediates. As demand for advanced heterocycles grows, pressure mounts to make them in greener, more scalable ways. Labs working at the intersection of green chemistry and exploratory synthesis have already started adapting: swapping out harsh coupling conditions for milder, catalytic alternatives. Experience in our lab shows that reliable access to compounds like this, made with lower-waste routes and minimal heavy metal contamination, lines up with tightening environmental policies. Loosening the grip on wasteful syntheses helps researchers uphold both efficiency and responsible stewardship.
On the innovation front, partnerships between fine chemical manufacturers and research groups may pave the way for broader adoption of advanced building blocks. Shared best practices in upscaling, through open communication and standardized batch testing, can raise the bar for reproducibility. The most impactful solutions come from feedback loops—researchers flagging bottlenecks, and producers adapting routes or packaging to cut down on waste or transportation damage. Our group has seen tangible benefits by opening channels with suppliers, often gaining earlier access to next-generation intermediates or troubleshooting support unavailable through pure catalogue orders.
Chemistry, more than most fields, depends on detail. Even as automated platforms and AI-driven selection tools surge in popularity, the day-to-day breakthroughs still come down to real people handling unpredictable compounds in lab settings. Earning trust in complex research starts with transparency—full disclosure of synthetic origins, analytical confirmation, and physical properties—as well as honest feedback on performance beyond analytical metrics. That’s how product quality evolves, and it’s why compounds with precise specifications but flexible application potential drive so much value, both in discovery science and applied R&D.
Mentoring young chemists and fostering open communication across teams means picking products not only by catalog number but by real-world experience, published data, and peer support. Early-career scientists, facing project pressures and finite budgets, count on compounds that keep experiments on schedule. Learning both from published literature and lived experience keeps expectations realistic. More importantly, it speeds up learning curves and makes for stronger collaborations, allowing creative chemistry instead of fire-fighting repeat failures.
It’s tempting to pigeonhole 4-Bromo-1-[(4-Methylphenyl)Sulfonyl]-1H-Pyrrolo[2,3-B]Pyridine as just another research intermediate, but the cross-pollination between fields reshapes that view. Medicinal projects use it for lead optimization, while polymer scientists look at how its shape and electron profile impact flexible display materials or photovoltaic films. Agrochemical teams, too, look for heterocycles that persist in challenging soil or aquatic conditions—but with lower formation of unwanted byproducts. After talking with colleagues across these disciplines, I’ve seen how a well-designed molecule enjoys a second life far from its original intent.
Universities and industry partners both benefit from building a repertoire of such intermediates. Educational settings may use this compound to teach students about modern synthetic approaches, how to read NMR spectra, or the challenge of real-world purification. Industry scientists harness the predictable behavior and scalable synthesis in demanding pipelines, moving from milligram to kilogram scale. Only a select few compounds manage to keep both groups satisfied—and this one checks those boxes thanks to its stability, versatility, and clear reactivity.
Looking at ways to get even more from this product, researchers can push for clearer batch histories, digital traceability, and environmentally conscious packaging. Packing materials that minimize static, batch certificates that log every process step, and barcode traceability cut down on returns, unknown contaminants, and unnecessary time spent “troubleshooting the supplier.” In our group, these small process changes made day-long delays much less common, freeing up time for actual discovery.
Academic-industry partnerships, when managed transparently, can push more routine adoption of tailored intermediates like this one. Open data sharing about reaction failures, degradation under different storage conditions, or compatibility with new catalytic systems creates a feedback culture that accelerates field-wide progress. Our own failed attempts to join old catalytic protocols with new intermediates remind me that learning happens both through success and honest admission of dead-ends.
Demand for distinct, well-characterized intermediates shows no signs of waning. For chemists hunting for the next breakthrough scaffold or seeking process gains on the bench, molecules like 4-Bromo-1-[(4-Methylphenyl)Sulfonyl]-1H-Pyrrolo[2,3-B]Pyridine represent a sweet spot: not so rare as to be out-of-reach, but unique enough to spark discovery. Decades of experience teach that the difference between routine and truly innovative science comes from small, thoughtful choices in reagents. Getting to that next level depends as much on well-chosen starting materials as on creative synthesis or screening.
Care in selection, commitment to transparency, and honest reviewer feedback build reputations and pipeline productivity for everyone in the supply chain. Whether running one flask at a time or feeding high-throughput platforms, thoughtful adoption of well-designed intermediates makes the future of chemical science just a bit more promising, more efficient, and more rewarding for all involved.